Information From Your Health Care Provider |
Basic informationRh incompatibility is a difference between an infant's blood type and that of its mother. This results in the destruction of the infant's red blood cells during pregnancy and after birth by antibodies from its mother's blood.
The baby of an Rh-negative (blood type) mother and an Rh-positive father may be Rh-positive. If the father is known to be Rh negative, there is no concern. During pregnancy, but more commonly during delivery, a small amount of the infant's blood is absorbed by the mother through the placenta, stimulating her body to produce antibodies against Rh-positive blood. The antibodies are produced after delivery, so the first infant is not affected. With each subsequent pregnancy, anti-Rh antibodies cross the placenta and may destroy fetal blood cells. The resulting anemia can be severe enough to cause fetal death. If the fetus survives, antibodies can cross to the baby during birth, causing jaundice and other symptoms shortly after birth.
Each pregnancy after the first one that involved different blood types. This includes ectopic pregnancies and spontaneous (miscarriage) and elective abortions.
Medical care early in pregnancy is important to determine the risk of Rh incompatibility and provide treatment if needed.
With prompt diagnosis, monitoring, and treatment, the outcome is generally good. Complications are rare.
diagnosis & treatmentIf you are pregnant and have Rh-negative blood type, you will be prescribed an anti-Rh gamma globulin injection (RhoGAM) at 28 weeks and again within 72 hours after delivery or at the end of a pregnancy for any reason. You may have an antibody titer drawn during pregnancy to see if you are producing anti-Rh antibodies. You do not need RhoGAM if your fetus is Rh-negative.
No limits after treatment.
No special diet.
notify our office ifYou have further questions about RH incompatibility.